Cargando…

Glycaemic variability and risk of adverse cardiovascular events in acute coronary syndrome

OBJECTIVE: The relationship between different glycaemic variability (GV) indexes and adverse cardiovascular outcomes is not well understood. This study aims to determine whether GV is related to the occurrence of adverse cardiovascular events in patients with acute coronary syndrome (ACS). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lei, Li, Feng, Liu, Huan-Huan, Zhang, Zhi-Yuan, Yang, Fan, Qian, Ling-Ling, Wang, Ru-Xing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643761/ https://www.ncbi.nlm.nih.gov/pubmed/36341514 http://dx.doi.org/10.1177/14791641221137736

Ejemplares similares

Glycaemic variability is associated with adverse cardiovascular outcomes in patients hospitalised with an acute myocardial infarction
por: Chai, Thora Y., et al.
Publicado: (2019)

Clinical characteristics of patients with premature acute coronary syndrome and adverse cardiovascular events after PCI
por: Shi, Xiao-Jun, et al.
Publicado: (2019)

Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome
por: Wang, Le, et al.
Publicado: (2020)

New genetic variants associated with major adverse cardiovascular events in patients with acute coronary syndromes and treated with clopidogrel and aspirin
por: Liu, Xiaomin, et al.
Publicado: (2021)

Effects of a Secondary Prevention Combination Therapy with beta-Blocker and Statin on Major Adverse Cardiovascular Events in Acute Coronary Syndrome Patients
por: Zhu, Ling, et al.
Publicado: (2020)

Risk factors for major adverse cardiovascular events after the first acute coronary syndrome
por: Okkonen, Marjo, et al.
Publicado: (2021)

Influence of the Triglyceride-Glucose Index on Adverse Cardiovascular and Cerebrovascular Events in Prediabetic Patients With Acute Coronary Syndrome
por: Guo, Qianyun, et al.
Publicado: (2022)

Correlation between serum cartilage oligomeric matrix protein and major adverse cardiovascular events within 30 days in patients with acute coronary syndrome
por: Chen, Hao, et al.
Publicado: (2021)

Associations between P2RY12 gene polymorphisms and risks of clopidogrel resistance and adverse cardiovascular events after PCI in patients with acute coronary syndrome
por: Li, Miaonan, et al.
Publicado: (2017)

MON-166 Excess Cardiovascular Events Despite Good Glycaemic Control
por: Ulahannan, Thomas, et al.
Publicado: (2019)

Impact of Plasma Exposure of Statins and Their Metabolites With Major Adverse Cardiovascular Events in Chinese Patients With Coronary Artery Disease
por: Zhou, Xiao-hong, et al.
Publicado: (2020)

The Role of NLRP3 Inflammasome Signaling on Arrhythmias in Diabetes
por: Zhang, Lei, et al.
Publicado: (2022)

Human papillomavirus vaccine-associated premature ovarian insufficiency and related adverse events: data mining of Vaccine Adverse Event Reporting System
por: Gong, Li, et al.
Publicado: (2020)

Glycaemic Variability and Hyperglycaemia as Prognostic Markers of Major Cardiovascular Events in Diabetic Patients Hospitalised in Cardiology Intensive Care Unit for Acute Heart Failure
por: Gerbaud, Edouard, et al.
Publicado: (2022)

Glucose fluctuations aggravate myocardial fibrosis via activating the CaMKII/Stat3 signaling in type 2 diabtetes
por: Zhang, Lei, et al.
Publicado: (2023)

CHADS(2) Scores in the Prediction of Major Adverse Cardiovascular Events in Patients with Cushing's Syndrome
por: Wang, Yuh-Feng, et al.
Publicado: (2014)

Development and Validation of a Nomogram of In-hospital Major Adverse Cardiovascular and Cerebrovascular Events in Patients With Acute Coronary Syndrome
por: Bo, Xiangwei, et al.
Publicado: (2021)

Calcineurin/NFATc3 pathway mediates myocardial fibrosis in diabetes by impairing enhancer of zeste homolog 2 of cardiac fibroblasts
por: Zhang, Lei, et al.
Publicado: (2023)

Serum miR-497-5p serves as a diagnostic biomarker for acute coronary syndrome and predicts the occurrence of major adverse cardiovascular events after percutaneous coronary intervention
por: Chen, Tao, et al.
Publicado: (2022)

New Indices for Predicting Glycaemic Variability
por: Ogawa, Akifumi, et al.
Publicado: (2012)

A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
por: Kong, Shuting, et al.
Publicado: (2021)

Elevated Remnant Cholesterol is Associated with Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome
por: Shao, QiaoYu, et al.
Publicado: (2022)

A comparable efficacy and safety between intracardiac echocardiography and transesophageal echocardiography for percutaneous left atrial appendage occlusion
por: Zhang, Zhi-Yuan, et al.
Publicado: (2023)

Do Elderly Patients with Atrial Fibrillation Have Comparable Ablation Outcomes Compared to Younger Ones? Evidence from Pooled Clinical Studies
por: Li, Feng, et al.
Publicado: (2022)

Relationship between Red Blood Cell Indices (MCV, MCH, and MCHC) and Major Adverse Cardiovascular Events in Anemic and Nonanemic Patients with Acute Coronary Syndrome
por: Zhang, Zhanyi, et al.
Publicado: (2022)

Prognostic Value of Admission Mean Corpuscular Volume for Major Adverse Cardiovascular Events following Stent Implantation in Nondiabetic and Diabetic Patients with Acute Coronary Syndrome
por: Cheng, Lele, et al.
Publicado: (2020)

The association between glycaemic control during hospitalization and risk of adverse events: A retrospective cohort study
por: Deng, Lan, et al.
Publicado: (2021)

Visit-to-visit variability in low-density lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease
por: Gu, Jun, et al.
Publicado: (2019)

Short Sleep Duration, Obstructive Sleep Apnea, Shiftwork, and the Risk of Adverse Cardiovascular Events in Patients After an Acute Coronary Syndrome
por: Barger, Laura K., et al.
Publicado: (2017)

Clinical implication of homocysteine in premature acute coronary syndrome female patients: Its distribution and association with clinical characteristics and major adverse cardiovascular events risk
por: Zhao, Yunfeng, et al.
Publicado: (2021)

Correlation between monocyte to high-density lipoprotein ratio and major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
por: Yu, Rong, et al.
Publicado: (2021)

Association between visit‐to‐visit blood pressure variability and adverse events in coronary artery disease patients after coronary intervention
por: Tsai, Tsung‐Ying, et al.
Publicado: (2022)

The 9p21 Locus Is Associated with Coronary Artery Disease and Cardiovascular Events in the Presence (but Not in the Absence) of Coronary Calcification
por: Gong, Ling, et al.
Publicado: (2014)

Eccentric hypertrophy predicts adverse events in patients undergoing percutaneous coronary intervention for acute coronary syndrome
por: Ha, Edward T., et al.
Publicado: (2021)

Plasma osteoprotegerin predicts adverse cardiovascular events in stable coronary artery disease: the PEACE trial
por: Ma, Teng, et al.
Publicado: (2023)

Editorial: Advances in predicting future adverse coronary events: the role of cardiovascular imaging and coronary physiology indices
por: Seitun, Sara, et al.
Publicado: (2023)

Predictors of coronary artery calcification and its association with cardiovascular events in patients with chronic kidney disease
por: Wang, Xue-rong, et al.
Publicado: (2021)

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)
por: Zinman, Bernard, et al.
Publicado: (2017)

The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention
por: Giantini, Astuti, et al.
Publicado: (2023)

Serum tryptase detected during acute coronary syndrome is significantly related to the development of major adverse cardiovascular events after 2 years
por: Pastorello, Elide Anna, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8ig5hhtb7hlpgr67jdfgbjpf2n